Zepbound

Zepbound

Product

by Eli Lilly and Company

Heard in 21 episodes across 18 shows since Jun 2026

Zepbound is a brand name for tirzepatide, an injectable prescription medication developed by Eli Lilly and Company. It is approved for chronic weight management in adults with obesity or who are overweight with weight-related medical conditions.

Discussed inMarkets46%Health & Science23%Politics15%Business8%

Episodes

21
across 18 shows

This week

0
episodes on 0 shows

Share of the conversation

Mentions of Zepbound per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.1‰0.2‰0.3‰Jul 10Aug 1Aug 24Sep 15Oct 7
Show the data
DayShare (7-day)Mentions
Aug 40.23‰1
Aug 120.11‰3
Aug 130.17‰2
Aug 140.21‰2
Aug 210.07‰2
Sep 10.03‰1
Sep 30.06‰1
Sep 80.07‰1
Sep 130.20‰5
Sep 200.03‰1
Sep 210.05‰1
Sep 230.08‰1
Sep 250.13‰2
Sep 300.08‰1
Oct 50.05‰1

The full trend: rank, tone and why it is trending →

Episodes

21 episodes featuring Zepbound, newest first

Zepbound · PodLume